The sacral nerve stimulation is therapy, in which the third sacral nerve can be directly stimulating through an electrical current to improve or alter the bladder and bowel functions. Besides, the treatment helps to restrain the pelvic pain. This technology is similar to a pacemaker where, instead of regulating a person's heartbeat, it helps to stimulate the bowel, sphincter, and bladder muscles to work correctly.
MARKET DYNAMICS
The sacral nerve stimulation market is anticipated to grow in the forecast, owing to the increasing number of cases of urge incontinence such as urinary tract infection (UTI), rising number of patients suffering from overactive bladder (OAB) and fecal incontinence. However, rise in geriatric population and increase in incidences of neurological disorders is likely to add novel opportunities in the forecast period for the market for forensic equipment and supplies.
MARKET SCOPE
The "Global Sacral Nerve Stimulation Market Analysis to 2028" is a specialized and in-depth study of the medical industry with a special focus on the global market trend analysis. The report aims to provide an overview of sacral nerve stimulation market with detailed market segmentation by product, application, end user, and geography. The global sacral nerve stimulation market is expected to witness high growth during the forecast period. The report provides key information on the market status of the leading sacral nerve stimulation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global sacral nerve stimulation market is segmented on the basis of product, application and end user. Based on product, the market is bifurcated into electrical muscle stimulation and transcutaneous electrical nerve stimulation. Based on the application, the market is categorized as urinary & fecal incontinence, urge incontinence, chronic anal fissure and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global sacral nerve stimulation market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sacral nerve stimulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting sacral nerve stimulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sacral nerve stimulation market in these regions.
MARKET PLAYERS
The report covers key developments in the sacral nerve stimulation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sacral nerve stimulation market are anticipated to have lucrative growth opportunities in the future with the rising demand for sacral nerve stimulation market in the global market. Below mentioned is the list of few companies engaged in the sacral nerve stimulation market.
The report also includes the profiles of key sacral nerve stimulation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Medtronic
- Boston Scientific Corporation
- Abbott
- Biocompare
- IntraPace, Inc.
- NeuroPace, Inc.
- Cyberonics, Inc.
- Synapse Biomedical Inc.
- Laborie, Inc.
- Nuvectra